MedTrace Logo

A 12 Week Study to Evaluate the Efficacy of an Eye Cream

NCT05807620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-30

No results posted yet for this study

Summary

This single center, open-label clinical study was conducted to assess the efficacy and tolerance of a topical eye cream when used over the course of 12 weeks by healthy women with moderate to severe under-eye dark circles, moderate under eye puffiness, and mild fine lines and wrinkles. A total of 37 subjects were enrolled into the study.

Conditions

  • Periorbital Hyperpigmentation
  • Periorbital Edema
  • Fine Lines
  • Wrinkle

Interventions

OTHER

Gentle Cleansing Lotion

Facial cleansing lotion to be used by study participants (morning and evening, 2x daily).

OTHER

Facial Moisturizer

Anti-aging facial moisturizer to be used by study participants after anti-aging daily serum before sunscreen (morning and evening, 2x daily).

OTHER

Sunscreen SPF 30

Neutrogena Ultra Sheer Dry Touch SPF 30. Sunscreen to be applied after application of the facial moisturizer in the morning. Participants were asked to reapply every 2 hours. Per FDA this intervention is an over the counter

Sponsors & Collaborators

  • Validated Claim Support

    collaborator UNKNOWN

  • Revision Skincare

    lead INDUSTRY

Principal Investigators

  • Anna Hardy · Validated Claim Support

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-05-01
Completion
2022-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05807620 on ClinicalTrials.gov